BiotechTube
Home/Pipeline/Prolia/XGEVA (Denosumab) Biosimilar

Prolia/XGEVA (Denosumab) Biosimilar

Bone Metastases / Osteoporosis

Process Scale‑upActive

Key Facts

Indication
Bone Metastases / Osteoporosis
Phase
Process Scale‑up
Status
Active
Company
NeuClone

About NeuClone

Australian biosimilar developer using a proprietary CHO platform to bring affordable biologics to market.

View full company profile

Therapeutic Areas

OncologyImmunologyBone HealthInfectious Diseases